These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33363477)

  • 1. Cardiac Autonomic Dysfunction and Incidence of
    Wessel N; Berg K; Kraemer JF; Gapelyuk A; Rietsch K; Hauser T; Kurths J; Wenzel D; Klein N; Kolb C; Belke R; Schirdewan A; Kääb S
    Front Physiol; 2020; 11():596844. PubMed ID: 33363477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of atrial sensing for new-onset atrial arrhythmias diagnosis and management in single-chamber implantable cardioverter-defibrillator recipients: Results from the THINGS registry.
    Biffi M; Iori M; De Maria E; Bolognesi MG; Placci A; Calvi V; Allocca G; Ammendola E; Carinci V; Boggian G; Saporito D; Grassini D; Giacopelli D; Statuto G; Ziacchi M
    J Cardiovasc Electrophysiol; 2020 Apr; 31(4):846-853. PubMed ID: 32064713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Autonomic Dysfunction and Incidence of Atrial Fibrillation: Results From 20 Years Follow-Up.
    Agarwal SK; Norby FL; Whitsel EA; Soliman EZ; Chen LY; Loehr LR; Fuster V; Heiss G; Coresh J; Alonso A
    J Am Coll Cardiol; 2017 Jan; 69(3):291-299. PubMed ID: 28104071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclinical atrial fibrillation detection with a floating atrial sensing dipole in single lead implantable cardioverter-defibrillator systems: Results of the SENSE trial.
    Thomas G; Choi DY; Doppalapudi H; Richards M; Iwai S; Daoud EG; Houmsse M; Kanagasundram AN; Mainigi SK; Lubitz SA; Cheung JW
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1994-2001. PubMed ID: 31328298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ability to remotely monitor atrial high-rate episodes using a single-chamber implantable cardioverter-defibrillator with a floating atrial sensing dipole.
    Hindricks G; Theuns DA; Bar-Lev D; Anguera I; Ayala Paredes FA; Arnold M; Geller JC; Merkely B; Dyrda KM; Perings C; Maglia G; Ploux S; Meyhöfer J; Blomström-Lundqvist C; Karjalainen P; Liang Y; Diemberger I; Wranicz JK; Barr C; Quartieri F; Timmel T; Bollmann A
    Europace; 2023 May; 25(5):. PubMed ID: 37038759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Magnetic Resonance Imaging-Derived Left Atrial Characteristics in Relation to Atrial Fibrillation Detection in Patients With an Implantable Cardioverter-Defibrillator.
    Hopman LHGA; van der Lingen ACJ; van Pouderoijen N; Krabbenborg J; Mulder MJ; Rijnierse MT; Bhagirath P; Robbers LFHJ; van Rossum AC; van Halm VP; Götte MJW; Allaart CP
    J Am Heart Assoc; 2023 Aug; 12(15):e028014. PubMed ID: 37489727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the incidence of atrial fibrillation in single-chamber implantable cardioverter defibrillator patients.
    Zweibel S; Cronin EM; Schloss EJ; Auricchio A; Kurita T; Sterns LD; Gerritse B; Lexcen DR; Cheng A
    Pacing Clin Electrophysiol; 2019 Feb; 42(2):132-138. PubMed ID: 30478983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Incidence of De Novo and Subclinical Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy and Cardiac Rhythm Management Device.
    Wilke I; Witzel K; Münch J; Pecha S; Blankenberg S; Reichenspurner H; Willems S; Patten M; Aydin A
    J Cardiovasc Electrophysiol; 2016 Jul; 27(7):779-84. PubMed ID: 27060297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
    Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
    Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of the Linox
    Marai I; Milman A; Diamante R; Gurevitz O; Barlev D; Lipchenka I; Nof E; Glikson M; Beinart R
    Indian Pacing Electrophysiol J; 2020; 20(4):137-140. PubMed ID: 31862483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart rate variability in atrial fibrillation: The balance between sympathetic and parasympathetic nervous system.
    Khan AA; Lip GYH; Shantsila A
    Eur J Clin Invest; 2019 Nov; 49(11):e13174. PubMed ID: 31560809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes.
    Swiryn S; Orlov MV; Benditt DG; DiMarco JP; Lloyd-Jones DM; Karst E; Qu F; Slawsky MT; Turkel M; Waldo AL;
    Circulation; 2016 Oct; 134(16):1130-1140. PubMed ID: 27754946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation increases the risk of recurrent ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients.
    Rusnak J; Behnes M; Reiser L; Schupp T; Bollow A; Reichelt T; Borggrefe M; Ellguth D; Engelke N; El-Battrawy I; Ansari U; Barre M; Weidner K; Müller J; Barth C; Meininghaus DG; Akin M; Bertsch T; Taton G; Akin I
    Arch Cardiovasc Dis; 2021; 114(6-7):443-454. PubMed ID: 33967015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of atrial fibrillation on early complications and one year-survival after cardioverter defibrillator implantation: results from the German DEVICE registry.
    Köbe J; Wasmer K; Andresen D; Kleemann T; Spitzer SG; Jehle J; Brachmann J; Stellbrink C; Hochadel M; Senges J; Klein HU; Eckardt L
    Int J Cardiol; 2013 Oct; 168(4):4184-90. PubMed ID: 23948108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Autonomic Nervous Activity in the Termination of Paroxysmal Atrial Fibrillation.
    Huang JH; Lin YK; Hsieh MH; Chen SA; Chiu WC; Chen YJ
    Pacing Clin Electrophysiol; 2017 Apr; 40(4):401-408. PubMed ID: 28181276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial tachyarrhythmias temporally precede fluid accumulation in implantable device patients.
    Andriulli JA; Moore HJ; Hettrick DA; Ousdigian KT; Johnson J; Markowitz SM
    Pacing Clin Electrophysiol; 2014 May; 37(5):554-61. PubMed ID: 24341570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Dx-AF study: a prospective, multicenter, randomized controlled trial comparing VDD-ICD to VVI-ICD in detecting sub-clinical atrial fibrillation in defibrillator patients.
    Shurrab M; Janmohamed A; Sarrazin JF; Ayala-Paredes F; Sturmer M; Williams R; Toal S; Lane C; Thorpe KE; Healey JS; Crystal E
    J Interv Card Electrophysiol; 2017 Oct; 50(1):57-63. PubMed ID: 28752228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy and safety of an implantable cardioverter-defibrillator lead with a floating atrial sensing dipole.
    Safak E; Schmitz D; Konorza T; Wende C; De Ros JO; Schirdewan A;
    Pacing Clin Electrophysiol; 2013 Aug; 36(8):952-62. PubMed ID: 23692262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of single-lead implantable cardioverter-defibrillator with atrial sensing dipole to detect atrial fibrillation and to reduce inappropriate therapy according to atrial sensing ON or OFF: Rationale and design of the SMART-CONTROL study, a prospective multicenter randomized trial.
    Gwag HB; Kim HR; Park SJ; Kim J; Chung TW; Choi JH; Kim JY; Park KM; On YK; Kim JS
    Am Heart J; 2022 Sep; 251():25-31. PubMed ID: 35568193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of rapid atrial pacing for termination of drug refractory atrial fibrillation: results of a dual chamber implantable cardioverter defibrillator trial.
    Gold MR; Leman RB; Euler DE
    Card Electrophysiol Rev; 2003 Dec; 7(4):341-4. PubMed ID: 15071249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.